Literature DB >> 25875944

Surveillance for hepatocellular carcinoma secondary to cardiogenic cirrhosis in patients with congenital heart disease.

Alexander Augustyn1, Lan Peng, Amit G Singal, Adam C Yopp.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25875944      PMCID： PMC4768748          DOI： 10.1007/s00392-015-0809-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  11 in total

1.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Authors:  Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael I D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge Marrero; Steven G Meranze; Sean J Mulvihill; James O Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

2.  Insights after 40 years of the fontan operation.

Authors:  Alvin J Chin; Kevin K Whitehead; Raymond L Watrous
Journal:  World J Pediatr Congenit Heart Surg       Date:  2010-10

3.  Hepatocellular carcinoma after the Fontan procedure.

Authors:  Sumeet K Asrani; Carole A Warnes; Patrick S Kamath
Journal:  N Engl J Med       Date:  2013-05-02       Impact factor: 91.245

Review 4.  Congenital heart disease and the liver.

Authors:  Sumeet K Asrani; Nina S Asrani; Deborah K Freese; Sabrina D Phillips; Carole A Warnes; Julie Heimbach; Patrick S Kamath
Journal:  Hepatology       Date:  2012-08-02       Impact factor: 17.425

5.  Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Andrea Gardini; Matteo Cescon; Giovanni Varotti; Francesco Cetta; Antonino Cavallari
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

6.  Juvenile hepatocellular carcinoma with congestive liver cirrhosis.

Authors:  Yuko Izumi; Naoki Hiramatsu; Ichiyo Itose; Takahiro Inoue; Akira Sasagawa; Satoshi Egawa; Tsutomu Nishida; Yoshimi Kakiuchi; Takashi Toyama; Fumihiko Nakanishi; Kazuyoshi Ohkawa; Kiyoshi Mochizuki; Tatsuya Kanto; Masahiko Tsujii; Tetsuo Takehara; Shingo Tsuji; Michio Kato; Akinori Kasahara; Norio Hayashi
Journal:  J Gastroenterol       Date:  2005-02       Impact factor: 7.527

7.  Hepatocellular carcinoma in an adult with repaired tetralogy of fallot.

Authors:  Nancy McCabe; Alton Brad Farris; Huiming Hon; Ryan Ford; Wendy M Book
Journal:  Congenit Heart Dis       Date:  2012-08-16       Impact factor: 2.007

8.  Hepatocellular carcinoma with cardiac cirrhosis.

Authors:  S S Ho; R Brown; B Fitzgibbon
Journal:  Med J Aust       Date:  1990-05-21       Impact factor: 7.738

9.  Hepatocellular carcinoma in two patients with cardiac cirrhosis.

Authors:  Teddy Saliba; Stephan Dorkhom; Eileen M O'Reilly; Emmy Ludwig; Bolorsukh Gansukh; Ghassan K Abou-Alfa
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-07       Impact factor: 2.566

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  2 in total

1.  When left turns to right: a congenital corrected transposition of the great arteries with an azygos continuation without another major cardiac abnormality.

Authors:  L A Mata Marín; C Lenzen; A Fach; R Hambrecht
Journal:  Clin Res Cardiol       Date:  2016-07-11       Impact factor: 5.460

Review 2.  Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review.

Authors:  Ji Hyun Sung; Ryotaro Sakamori; Ryoko Yamada; Teppei Yoshioka; Sadatsugu Sakane; Yuki Tahata; Minoru Shigekawa; Takahiro Kodama; Hayato Hikita; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.